HARDWARE % min read

Vision-Restoring Chip Helps First Stargardt Patient Read Again

Vision-Restoring Chip Helps First Stargardt Patient Read Again
Photo by Dmitry Ratushny / Unsplash

Science Corporation has implanted its PRIMA retinal chip in the first patient with Stargardt disease, marking a significant milestone for the company founded by former Neuralink co-founder Max Hodak. Stargardt disease gradually destroys central vision and currently has no cure, affecting roughly 150,000 people worldwide. The patient received the implant in May as part of a clinical trial in Australia and was able to identify a letter during the first rehabilitation session and read a word during the second. The system works through a tiny chip implanted in the retina and camera-equipped glasses that transmit visual information to the device. For now, the technology provides only a small black-and-white area of vision, but it can deliver sharp, high-contrast images. Science says the next generation of implants will expand the field of view and improve detail, with human testing expected within a year. Hodak sees retinal implants as part of the broader brain-computer interface field and believes the underlying technology could eventually support treatments for a range of neurological conditions. The company ultimately aims to move beyond vision restoration and develop advanced interfaces capable of interacting directly with the brain.

Read the full story on TechCrunch →